14 June, 2022
Donaldson Acquires Purilogics, Expanding Life Sciences Portfolio
Donaldson has announced the acquisition of Purilogics, LLC, an early-stage biotechnology company that leverages a novel technology platform for the development of best-in-class membrane chromatography products. Purilogics’ proprietary formulations and processes create membranes that have significant competitive advantages, enabling faster and more cost-effective production of increasingly complex biologic drugs.